BETA-2 CROSSLAPS CTX 1 EDTA PLASMA

image not found

NABL Cap Accredited 
The Beta-2 CrossLaps (CTX-1) EDTA Plasma test measures C-terminal telopeptides of type I collagen, a key biomarker of bone resorption. It helps evaluate bone turnover rates and is commonly used in the assessment of osteoporosis and treatment monitoring. Metropolis Healthcare uses advanced immunoassay technology to deliver highly accurate and reproducible CTX-1 measurements. This test is valuable for understanding bone health status and tracking the effectiveness of therapies that influence bone metabolism. It is performed with precision and strict quality standards at Metropolis Healthcare.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 2,200.00

Sample Type: EDTA PLASMA

Fasting Not Required


Notes: B0026

Frequently Asked Questions (FAQ's):

What does the Beta-2 CrossLaps CTX-1 test include at Metropolis Healthcare?
It measures CTX-1 levels in EDTA plasma to assess bone resorption and overall bone turnover activity.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced immunoassay platforms to accurately quantify CTX-1, ensuring reliable bone health evaluation.

Who should take the Beta-2 CrossLaps CTX-1 test at Metropolis Healthcare?
Individuals being evaluated for osteoporosis, metabolic bone disorders, or bone loss monitoring may be advised to undergo this test.

Is any preparation needed before giving a sample at Metropolis Healthcare?
Your doctor may recommend a morning sample for consistency, but no special fasting is typically required.

How quickly will Metropolis Healthcare provide the results?
Results are reported within the standard turnaround time for advanced hormone and biomarker testing.

Are CTX-1 test results reliable at Metropolis Healthcare?
Yes, Metropolis Healthcare follows stringent quality control procedures to ensure precise and dependable CTX-1 measurements.

Can this test help monitor osteoporosis treatment?
Yes, changes in CTX-1 levels can help evaluate the effectiveness of bone resorption therapies.

Do I need a prescription for this test at Metropolis Healthcare?
A prescription is recommended so your clinician can correlate the results with your bone health status.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab